Jnba Financial Advisors Abbott Laboratories Transaction History

Jnba Financial Advisors

$980 Million
Q3 2024

A detailed history of Jnba Financial Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Jnba Financial Advisors holds 13,476 shares of ABT stock, worth $1.59 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

13,476

Previous 13,576 0.74%

Holding current value

$1.59 Million

Previous $1.41 Million 8.94%

% of portfolio

0.16%

Previous 0.15%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$100.07 - $118.13 $10,007 - $11,813	-100 Reduced 0.74%	13,476 $1.54 Million
Q2 2024 Jul 22, 2024	BUY	$100.73 - $112.44 $5,036 - $5,622	50 Added 0.37%	13,576 $1.41 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $89,696 - $99,066	-819 Reduced 5.71%	13,526 $1.54 Million
Q4 2023 Feb 07, 2024	SELL	$90.19 - $110.4 $19,030 - $23,294	-211 Reduced 1.45%	14,345 $1.58 Million
Q3 2023 Nov 02, 2023	BUY	$95.53 - $114.62 $477 - $573	5 Added 0.03%	14,556 $1.41 Million
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $8,566 - $9,544	-85 Reduced 0.58%	14,551 $1.59 Million
Q1 2023 May 01, 2023	SELL	$96.86 - $114.01 $5,617 - $6,612	-58 Reduced 0.39%	14,636 $1.48 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $15,019 - $17,620	-158 Reduced 1.06%	14,694 $1.61 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $2,709 - $3,136	-28 Reduced 0.19%	14,852 $1.44 Million
Q2 2022 Jul 22, 2022	BUY	$102.07 - $123.37 $14,698 - $17,765	144 Added 0.98%	14,880 $1.62 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $58,378 - $71,188	-512 Reduced 3.36%	14,736 $1.74 Million
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $8,087 - $9,902	-70 Reduced 0.46%	15,248 $2.15 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $51,797 - $57,302	-444 Reduced 2.82%	15,318 $1.81 Million
Q2 2021 Aug 04, 2021	BUY	$105.79 - $124.53 $95,211 - $112,077	900 Added 6.06%	15,762 $1.83 Million
Q4 2020 Jan 25, 2021	SELL	$105.0 - $114.42 $32,760 - $35,699	-312 Reduced 2.06%	14,862 $1.63 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $6,873 - $8,346	-75 Reduced 0.49%	15,174 $1.65 Million
Q2 2020 Jul 24, 2020	SELL	$76.57 - $98.0 $45,252 - $57,918	-591 Reduced 3.73%	15,249 $1.39 Million
Q1 2020 May 01, 2020	BUY	$62.82 - $91.86 $1,570 - $2,296	25 Added 0.16%	15,840 $1.25 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $5,495 - $6,118	-70 Reduced 0.44%	15,815 $1.37 Million
Q3 2019 Nov 01, 2019	SELL	$81.84 - $88.74 $23,733 - $25,734	-290 Reduced 1.79%	15,885 $1.33 Million
Q2 2019 Jul 26, 2019	BUY	$72.88 - $85.0 $21,864 - $25,500	300 Added 1.89%	16,175 $1.36 Million
Q1 2019 May 01, 2019	SELL	$66.22 - $80.06 $81,318 - $98,313	-1,228 Reduced 7.18%	15,875 $1.27 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $462,656 - $524,123	-7,057 Reduced 29.21%	17,103 $1.24 Million
Q3 2018 Nov 01, 2018	BUY	$60.81 - $73.36 $404,933 - $488,504	6,659 Added 38.05%	24,160 $1.77 Million
Q2 2018 Jul 17, 2018	SELL	$57.57 - $63.54 $21,300 - $23,509	-370 Reduced 2.07%	17,501 $1.07 Million
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $22,733 - $25,702	-404 Reduced 2.21%	17,871 $17.9 Million
Q4 2017 Jan 31, 2018	SELL	$53.68 - $57.47 $68,603 - $73,446	-1,278 Reduced 6.54%	18,275 $1.04 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $24,078 - $26,873	501 Added 2.63%	19,553 $1.04 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,052	19,052 $926,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.

Account

Jnba Financial Advisors Abbott Laboratories Transaction History